This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Rie Kunisada: Innovator in Diabetes Therapeutics
Introduction
Rie Kunisada is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of diabetes research, particularly in developing therapeutic agents. Her innovative work focuses on utilizing polynucleotides to combat diabetes effectively.
Latest Patents
Rie Kunisada holds a patent for a prophylactic or therapeutic agent for diabetes. This invention provides a drug that contains a polynucleotide, such as miR-199b*, which plays a crucial role in diabetes treatment. The patent also outlines methods for screening and determining susceptibility to this therapeutic drug by measuring the expression levels of the polynucleotide.
Career Highlights
Rie Kunisada is associated with Takeda Pharmaceutical Company Limited, where she continues to advance her research in diabetes therapeutics. Her work has garnered attention for its potential to improve the lives of those affected by diabetes.
Collaborations
Rie collaborates with notable colleagues, including Hirokazu Matsumoto and Hidefumi Uchiyama, to further enhance her research and development efforts.
Conclusion
Rie Kunisada's innovative contributions to diabetes therapeutics highlight her role as a leading inventor in the field. Her work not only showcases her expertise but also promises to make a significant impact on diabetes treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile